Biomimetic Culture Reactor for Whole-Lung Engineering by Raredon, Micha Sam Brickman et al.
ORIGINAL RESEARCH ARTICLE Open Access
Biomimetic Culture Reactor for Whole-Lung Engineering
Micha Sam Brickman Raredon,1–3 Kevin A. Rocco,1,2 Ciprian P. Gheorghe,4 Amogh Sivarapatna,1,2 Mahboobe Ghaedi,2
Jenna L. Balestrini,2,5 Thomas L. Raredon,6 Elizabeth A. Calle,1,2 and Laura E. Niklason1,2,*
Abstract
Decellularized organs are now established as promising scaffolds for whole-organ regeneration. For this work to
reach therapeutic practice, techniques and apparatus are necessary for doing human-scale clinically applicable
organ cultures. We have designed and constructed a bioreactor system capable of accommodating whole
human or porcine lungs, and we describe in this study relevant technical details, means of assembly and oper-
ation, and validation. The reactor has an artiﬁcial diaphragm that mimics the conditions found in the chest cavity
in vivo, driving hydraulically regulated negative pressure ventilation and custom-built pulsatile perfusion appa-
ratus capable of driving pressure-regulated or volume-regulated vascular ﬂow. Both forms of mechanical actu-
ation can be tuned to match speciﬁc physiologic proﬁles. The organ is sealed in an elastic artiﬁcial pleura that
mounts to a support architecture. This pleura reduces the ﬂuid volume required for organ culture, maintains the
organ’s position during mechanical conditioning, and creates a sterile barrier allowing disassembly and mainte-
nance outside of a biosafety cabinet. The combination of ﬂuid suspension, negative-pressure ventilation, and
physiologic perfusion allows the described system to provide a biomimetic mechanical environment not
found in existing technologies and especially suited to whole-organ regeneration. In this study, we explain
the design and operation of this apparatus and present data validating intended functions.
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Introduction
The current standard for treating chronic terminal lung
disease is whole-organ transplantation. Although the pro-
cedure can give patients many more years of life, trans-
plantation is often delayed due to a shortage of viable
organs, and patients who do receive an organ must take
immunosuppressive drugs for the rest of their lives. An al-
ternative would be to grow new organs from a patient’s
owncells, and in2010, two separate groups showed thepo-
tential for ex vivo lung regeneration using decellularized
whole-organ scaffolds.1,2 In these studies, lungs were
taken from a rat and perfused with detergent-based solu-
tions that removed cellular material. Such decellulariza-
tion techniques, when performed with care, leave the
extracellular matrix largely intact, preserving the micron-
scale histological architecture of the lungs and presenting
a fully vascularized whole-organ scaffold.3–5 In principle,
these scaffolds can then be repopulated with cells derived
from the patient, yielding a transplantable artiﬁcial organ
with little or no immunogenicity.6
Specialized bioreactors are essential for this type of
whole-organ engineering work, whether it be for lungs
or other organs such as livers.7 For any organ type, re-
actors must provide adequate mass transport to all por-
tions of the tissue, control media characteristics such as
pH and oxygen, and should provide an organ-speciﬁc
mechanical environment that approximates the bio-
physical signals experienced in vivo.8 In the lung,
shear stresses due to perfusion are important mediators
of endothelial phenotype,9 and cyclic ventilation is
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known to affect organ development in utero and exerts
effects on epithelium during regeneration in vitro.10,11
Any system for the culture of whole lung should there-
fore allow ﬁne control of both breathing and perfusion,
in addition to maintaining sterility and allowing for
suitable nutrient and gas exchange.
The predominant commercially available apparatus
designed to work with human lungs are ex vivo lung per-
fusion (EVLP) systems, used in the pioneering clinical
work of the Lund group12–16 and the Toronto group.17–19
In EVLP, lungs are taken from a donor, cannulated with
ﬂow lines, placed under mechanical perfusion and ventila-
tion in the operating room, and monitored before trans-
plant for relevant outputs such as DPO2 and vascular
resistance. While this process mirrors some aspects of
the whole-organ regeneration process, EVLP systems are
not well suited for long-term tissue culture. Because
EVLP systems are designed for surgical use in an operating
room, they do not create a sterile barrier around the organ.
During procedures, the lungs are placed on a hard surface
and support their own weight, creating a mechanical envi-
ronment very different from that found in the body; when
in vivo, the lungs are suspended in ﬂuid and held in place
by thin pleural membranes. In addition, these systems use
positive-pressure ventilators to breathe the lungs, and
there is substantial evidence that positive-pressure ventila-
tion can cause mechanical tissue damage and incite bio-
chemical cascades that negatively alter pulmonary cell
behavior and morphology.20,21 Although the various de-
signs now used by laboratories for EVLP have some tech-
nical variation (see these references22–27), no currently
published EVLP apparatus is well suited for long-term
(e.g., more than 1 day) ex vivo whole-lung culture.
Based on the needs described above, we determined a
set of functional parameters for a regenerative whole-
lung bioreactor. Sterility was of primary importance,
and care was taken to build components from materials
that could be frequently autoclaved.We designed our sys-
tem to allow for sterile benchtop maintenance. Since ven-
tilator injury can be somewhat prevented by preserving
end-expiratory lung volume through a maintenance of
negative pleural pressure,28 an overarching goal of this
project was to develop an apparatus capable of reliable
negative pressure ventilation. Suspending the cultured
lung in ﬂuid encased by a ‘‘pleural membrane’’ was
deemed preferable, as it more closely mimics the condi-
tions found in the body. Previous studies with small an-
imal models suspended the entire regenerating organ in
the culture media. However, at human scale, this tech-
nique would have proven prohibitively expensive. We,
therefore, aimed to minimize media volume as much as
possible and to isolate media to contact with the tissue
itself. We also designed the system to be sufﬁciently com-
pact to be transportable between workstations. Most im-
portantly, the bioreactor had to be capable of mirroring
breathing and pulmonary vascular ﬂow proﬁles corre-
sponding to physiologic proﬁles, as the utmost goal is
to provide a mechanical and chemical environment
that delivers appropriate cues to cultured lung cells.




The bioreactor consists of a ventilation apparatus, per-
fusion apparatus, and an organ culture chamber. The
breathing and perfusion units are integrated into a
wheeled cart that acts as a mobile platform for the
organ chamber. Technical drawings of the apparatus
are shown in Figure 1.
Table 1. Functional Parameters for Regenerative Ex Vivo Lung Culture
Parameter Required specifications Commercial EVLP systems
Sterility Fully sealed, sterile for long culture periods
(1–21 days)
Designed for operating room use, open to room
air, nonsterile
Ventilation method Negative pressure Positive pressure
Ventilation rate 0–15 breaths per minute Dependent on model and tissue used. Generally,
7–15 breaths per minute, 100mL$kg1$min10–750mL per breath
Ventilation media Fluid or air Air
Perfusion method Pulsatile Continuous
Perfusion rate 0–90 beats per minute Dependent on model and tissue used. Maximum
flow generally considered 4 L/min0–50mL per beat (up to 4.5 L/min)
Medium volume outside of tissue Minimal (<1 L), mechanism to maintain this volume
when culturing decellularized (permeable) tissue
0 L (used with intact native tissue)
Disassembly and storage Allow for benchtop-disassembly and sterile storage
of decellularized lung tissue
Not designed for manipulation or storage of lungs
outside of operating room
Local tissue environment Fluid suspension In contact with air, resting on platform
EVLP, ex vivo lung perfusion.
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FIG. 1. Technical drawings of the bioreactor. The apparatus is composed of three mechanical modules: the
organ chamber (A), ventilation apparatus (B), and perfusion apparatus (C). These three modules are linked
through ½† internal diameter tubing (not shown), with ﬂow paths dependent on experimental conditions. The
lung is sealed within a silicone pleura (A.7) and any cannulae linked to the cannulation port (A.8, drawn
schematically). The construct is then suspended from the removable stainless steel internal architecture (A.9)
through loops in the silicone pleura, and ﬂow lines run from the cannulation port to the sealing ring (A.5).
Quick-connect ﬁttings (A.6) allow easy management of ﬂow lines to and from the reactor. Oscillation of the
hydraulic cylinder (B.5) drives ﬂuid ﬂow in/out of the top plate ventilation dome (A.1), causing ﬂexing of the
artiﬁcial diaphragm (A.3). Expansion and contraction of the polyethylene bellows pump in the perfusion
apparatus (C.4) drives cyclical pulsatile vascular ﬂow. Ventilation can be varied from 0 to 15 bpm at 10–750mL
per cycle. Perfusion can be varied from 0 to 94 bpm at 5–55mL per cycle. bpm, beats per minute.
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The organ chamber consists of a 26.5 L glass jar
(Fig. 1, A.10), sealed under compression between a
top and a bottom plate (A.1 and A.11) clamped with
thumbscrews and drop bars (A.2). Handles allow for
maneuvering and transport of the ﬁlled chamber. The
top plate has eight ports for ﬂuid ﬂow, with sterile-
disconnect quick-connect ﬁttings (A.4).
Directly beneath the top plate is a silicone membrane
(A.3) that generates the seal against the jar/organ cham-
ber. This membrane acts as an artiﬁcial diaphragm in
the reactor, forming a compliant wall for a variable-
volume ﬂuid reservoir in the top plate. The membrane
is sealed to the top plate by a custom-machined polysul-
fone ring (A.5) that isolates the hydraulic ﬂuid behind
the diaphragm from the interior of the jar, while allow-
ing ﬂuid ﬂow through the assembly.
Descending from the top plate assembly is a detach-
able stainless steel architecture (A.9) that helps to posi-
tion and orient the organ within the organ chamber,
providing anchor points for the perfused organ (A.6).
This structure doubles as a stand for the upper portion
of the organ chamber and the attached organ when dis-
assembled and worked with on a benchtop, allowing
manual access to the interior of the organ chamber
without physical disruption of the growing construct.
The organ itself is placed within a custom-fabricated
silicone pleura (A.7) that is sealed by a 4-inch diameter
cannulationport (A.8). The purpose of the silicone pleura
is severalfold. First, it creates an isolated media reservoir
immediately surrounding the tissue, which minimizes
culture medium requirements because it is not necessary
to ﬁll the entire glass bioreactor (25 L) with the medium.
Second, it holds the organ in a desired position and ori-
entation within the reactor throughout decellularization,
seeding, and mechanical conditioning, even when sub-
merged and ventilated with air. And third, it generates
a sterile barrier around the organ, allowing the discon-
nection, storage, and transport of the lung outside of
the bioreactor pre- and post-culture. The artiﬁcial pleura
is highly elastic, made from Shore 10A hardness material
with 1,000% elongation at break, which allows it to ex-
pand and contract with the organ during perfusion and
ventilation. The cannulation port contains junctions for
arterial, venous, tracheal, and drainage/pressure adjust-
ment lines. This pleural assembly is one of the key com-
ponents of the design, which, along with the artiﬁcial
diaphragm, sets this design signiﬁcantly apart from
other whole-lung perfusion apparatus.
The ventilation apparatus (B) cyclically pumps ﬂuid
into and out of the ﬂuid reservoir in the top plate (A.1).
Driven by a DC motor coupled to a hydraulic cylinder
through a variable-swing eccentric disc (B.2, B.4, and
B.5, respectively), the apparatus is capable of pumping
ﬂuid volumes between 10 and 1,000mL in a sinusoidal
pattern at rates between 1 and 15 cycles per minute,
thereby providing a means to breathe both human- and
large animal-sized lungs at physiological rates and vol-
umes. The expansion and contraction of the diaphragm
membrane (A.3) drives volume changes in the jar,
which subsequently cause the silicone pleura and encased
organ to expand or contract, pulling and pushing ﬂuid
from an attached reservoir connected to the trachea.
Vascular perfusion is driven by a bellows pump
(C.1–C.6) that advances ﬂuid around a vascular loop
that includes both a media reservoir and the vascular
conduits of the organ. The pump is capable of perfus-
ing 0–55mL per stroke at rates between 0 and 94 cycles
per minute, thereby encompassing most human phys-
iological conditions for lung perfusion. Two one-way
silicone poppet/duckbill valves (C.3) direct media ﬂow.
During operation, it ismost useful to look at the reactor
as a set of ﬁve distinct ﬂuid compartments. Supplemen-
tary Figure S1 shows a schematic that groups these ﬁve
compartments, and Supplementary Table S1 details the
speciﬁc location and purpose of each. The schematic
also includes various ﬂow paths, relief valves, check
valves, and control consoles necessary for operation.
Bioreactor construction
Organ chamber. Borosilicate glass (26.5 or 17 L;
Simax) jar (A.10) was purchased from Friedrich &
Dimmock. Top plate (A.1) and bottom plate (A.11)
were laser cut from 1/8† and 1/4† aluminum, respec-
tively. Diaphragm dome was hand turned on a lathe
out of aluminum sheet to match a machined mandrel
designed to have a volume of 0.75 L. Dome and top
cap foundation were welded together to create an air-
tight seal, and ½† national pipe thread (NPT) ﬁttings
attached. All ports were designed to accommodate ½†
NPT to valved quick-connect ﬁttings (A.4; Colder),
accommodating ½† internal diameter tubing. A dia-
phragm (A.3) was cut from 1/8† thick platinum-
cured silicone to match the top plate port pattern. A
sealing ring (A.5) was machined out of high-
temperature polysulfone (Radel) to hold this dia-
phragm to the top plate (A.1), which isolates the
space between the dome and the diaphragm while
still allowing unimpeded ﬂow through the quick-
connect ports; this ring is secured against the top cap
by machine screws passing through small holes in the
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diaphragm. The drop bars and thumbscrews (A.2) were
machined from brass and electroplated with nickel.
Stainless steel handles were attached to both the top
and bottom cap to allow physical transport of the bio-
reactor unit, and exposed aluminum pieces were pow-
der coated to prevent wear and oxidation (blue in
Figs. 2 and 5). The interior anchoring structure (A.9),
which would be in contact with ﬂuid, was made either
from high-density polyethylene or 316 stainless steel. It
consists of four threaded rods that attach through
FIG. 2. Setup, perfusion, and ventilation. A lung is isolated, cannulated for arterial, venous, and tracheal ﬂow,
attached to a cannulation port, and sealed within an appropriately sized silicone pleura (A). Corresponding
ﬂow lines are attached, and the assembled construct is placed within the organ chamber and suspended from
the internal architecture (B). Arterial perfusion of the construct displays pressure proﬁles similar to those found
in vivo, complete with dicrotic notch valve closing (C). Venous outﬂow displays regular smooth pressure curves
(D). Pressure within the trachea ﬂow line oscillates due to negative-pressure ventilation (E). Pressure in the
arterial line during simultaneous perfusion and ventilation can be seen in (F), with high frequency oscillations
corresponding to 20 bpm perfusion and the lower sinusoidal modulation corresponding to 2 bpm ventilation.
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modiﬁed quick-disconnect joints to the polysulfone
sealing ring and two laser cut crosspieces.
Ventilation module. ADC gear motor (B.2, 0–15 rpm,
570 in./lbs torque) was purchased from Bison Gear and
Engineering. Three inches diameter hydraulic cylinder
(B.5) and associated hardware were purchased from
Fabco-Air. A module to mount these components
(B.3) was constructed from ½† steel plate, allowing ac-
cess to the drive shaft and attachment points for alter-
nate hydraulic cylinders as required. A variable-arm
cam (B.4) to join the cylinder to the motor was ma-
chined from 1† aluminum, with offset points drilled
at locations corresponding to ventilation volumes at
50mL intervals from 150 to 750mL. A control box
(B.1) was mounted to allow variable speed control of
the motor. The bioreactor cart (B.7) was built around
this module from 1† aluminum extrusion.
Perfusion module. A 2½† diameter bellows metering
pump was purchased from Gorman-Rupp and disman-
tled to salvage the polyethylene bellows (C.4) and silicone
poppet/duckbill valves (C.3). A DC gear motor (C.2, 0–
94 rpm, 160 in./lbs torque) was purchased from Bison
as above. A drive-shaft reducing coupling (C.6) was ma-
chined to allow the motor to drive the bellows. A steel
mounting bracket was fabricated to bolt the bellows
and drive motor together. The assembly was mounted
within a portable aluminum-extrusion module designed
to lock into the lower part of the ventilation cart (C.5).
Silicone pleura and cannulation port. Hollow bronze
armatures were handmade in the shape of the desired
pleura. Clinical computed tomography scans from de-
identiﬁed patients were used to determine optimal sizing
and spacing of lung lobes, and armatures were created to
accommodate a range of patient sizes. These armatures
always contained a cylindrical portion that matched the
diameter of the desired cannulation port (A.8). Silicone
(either Smooth-On Dragon Skin 10 or Dow Corning
SilasticMDX4-4210) was mixed according to the man-
ufacturer’s instructions, degassed, and gently poured
over the armatures. The armature was continually ro-
tated during coating to prevent run off. Once the arma-
ture was entirely covered, precast silicone attachment
loops were pressed into the surface at desired points,
and boiling water was pumped through the hollow inte-
rior to rapidly cure the polymer. Post curing was com-
pleted overnight at room temperature. The cured pleura
was then peeled from the armature, cleaned, and trimmed
to ﬁt a given cannulation port. The cannulation ports
were machined from high-density polyethylene or Teﬂon
and usually contained four barbed ﬁttings on each side,
allowing attachment and through-ﬂow of the venous,
arterial, tracheal, and pleural lines.
Lung harvest
All animal experimental work was approved by Yale
University’s Institutional Animal Care and Use Com-
mittee. Yorkshire Swine ranging in weight from 20 to
30 kg were anesthetized using an intramuscular injec-
tion of Telazol (4.4mg/kg), Ketamine (2.2mg/kg),
and Xylazine (2.2mg/kg). Once anesthetized, animals
were administered heparin (300U/kg) through an in-
travenous catheter, which was allowed to circulate for
15min before euthanizing with Euthasol (85mg/kg).
Following euthanasia, an incision was made inferior
to the costal margin and the diaphragm was punctured
to collapse the lungs. The chest cavity was accessed
and the lungs perfused through the pulmonary artery
with lactated ringer’s solution (Hospira) containing
100U/mL heparin (Sigma) and 1lg/mL sodium nitro-
prusside (Sigma). The lungs, heart, and trachea were
excised en bloc and placed into 4C lactated ringer’s
solution containing 5% penicillin/streptomycin (Gibco),
2% amphotericin B (Sigma), and 1% gentamicin (Gibco)
for transport.
Bioreactor operation
During hydraulically driven negative pressure ventila-
tion, the breathing apparatus cyclically increases and de-
creases the volume of the breathing compartment ﬂuid
found in the upper portion of the organ chamber. This
volume oscillation in the upper portion of the organ
chamber drives volume oscillations in the lower two res-
ervoirs, the jar reservoir and pleural space, which are
both ﬁlled with ﬂuid and sealed from the atmosphere.
The changes here then cause ﬂuid to be drawn into
and pushed out of the lungs from the tracheal reservoir,
which is open to atmospheric pressure. The tracheal res-
ervoir takes the form of a large polyethylene media bag.
This can be a sterile reservoir for media or air. Separate
input and output lines, regulated by one-way valves,
minimize trachea-line dead space. This ensures maxi-
mum delivery of fresh media or air to the lung during
ventilation and allows the medium to be replenished
with nutrients and oxygen during ﬂuid breathing. This
setup mimics pulmonary negative pressure ventilation-
driven in vivo by the expansion and relaxation of the
rib cage and diaphragm. Vascular perfusion can be
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either pressure or volume regulated depending on the
setup; ﬂow is drawn from a vascular reservoir and is
driven into the pulmonary artery by the custom bel-
lows pump.
Perfusion and breathing demonstration
In a laminar ﬂow hood, lungs were dissected and can-
nulas were sutured in the pulmonary artery, trachea,
and pulmonary veins and connected to the vascular
and pulmonary ports. The lung/port assembly was se-
cured inside a sterilized silicon pleura and loaded
into the bioreactor chamber. Pulmonary artery and tra-
cheal ports were connected to the bioreactor cap and
connected with their respective pumps using 0.5 inch
diameter tubing (Masterﬂex) and quick-connects
(Colder). Venous return was collected from the venous
cannulae and the pleural space and was returned to the
vascular pump through the venous pathway shown in
Supplementary Figure S1. TruWave pressure transduc-
ers (Edwards) were placed in-line and connected to a
PowerLab acquisition system and recorded with the
LabChart 5.0 software (ADInstruments). Data were
exported into Microsoft Excel (Microsoft) for analysis.
Lung cannulation and bioreactor assembly were com-
pleted within 2 h of explant.
For short-term experiments, lung vasculature was per-
fused with either phosphate-buffered saline (PBS) or
Lactated Ringer’s solution, and the trachea was breathed
using either PBS or room air, depending upon the exper-
iment. Vascular ﬂow rates varied from 0 to*2 L/min, at
pulse rates ranging from 0 to 66 bpm. Breathing rates
varied from 0 to 7.1 brpm, with tidal volumes between
0 and 300mL depending upon the experiment. Demon-
stration experiments were limited to 3 h in duration
per lung.
24-Hour bioreactor-mounted lung culture
Left lobes were cannulated, and the bioreactor was as-
sembled in a similar manner as above. Under sterile
conditions, the vasculature perfusion lines were con-
nected to the vascular pump and a sterile 20 L reservoir
bag, and the perfusion system was loaded with 10 L of
Dulbecco’s modiﬁed Eagle’s medium (DMEM) high
glucose medium (Gibco) with 10% fetal bovine serum
(FBS), 2% penicillin/streptomycin, 0.4% amphotericin
B, and 0.2% gentamicin. The airway was ﬁlled using
the same medium recipe and connected to a separate
20 L reservoir. Media contacting components were ei-
ther autoclaved or soaked in 95% ethanol for 4 h and
left to dry overnight before use. Perfusion was main-
tained at 120mL/min (24.5mL/stroke, 5 bpm), while
the breathing diaphragm displacement volume was
set at 300mL and a rate of 2 cycles per minute.
Histology and immunoﬂuorescence
At the end of the culture period, the bioreactor was dis-
assembled and tissue was sectioned and ﬁxed in 10%
natural buffered formalin for 4 h and placed in 70%
ethanol overnight, followed by embedding and section-
ing into 5lm slices. Sections were stained with hema-
toxylin and eosin (H&E) to examine global tissue
architecture and cellularity.
For immunoﬂuorescent analysis, slides were deparafﬁ-
nized using xylene and rehydrated in water. Antigen re-
trieval was performed in 1mM EDTA, 10mM Tris, and
0.05% Tween-20 buffer at pH 9 for 20min at 75C and
allowed to cool to room temperature for 20min. After
blocking sections with PBS containing 10% FBS and
0.2% Triton X-100 for 45min, primary antibodies were
used against CCSP (07-623, 1:100; Millipore), Pro-SPC
(ab40879; Abcam), AQP-5 (AB3559-50UL, 1:500; Milli-
pore), PCNA (ab29, 1:500; Abcam), and PECAM-1
(ab28364, 1:100; Abcam) for 2 h at room temperature.
After washing slides with PBS, corresponding second-
ary antibodies (Alexa Fluor 555) were used at 1:500
dilution for 45min. Mounting medium containing 4’,
6-diamidino-2-phenylindole (DAPI)was applied to slides
to visualize nuclei, and coverslips were placed to seal
slides. The slides were visualized using a Leica DMI6000
B ﬂuorescence microscope.
qRT-PCR
Real-time quantitative RT-PCR (qRT-PCR) was used
to determine the expression of epithelial and endothe-
lial markers in the native pig lung and the pig lung cul-
tured in bioreactor for 24 h. Portions of lung tissue
were taken from each experimental condition (biolog-
ical replicate n = 1) and were used to prepare cDNA for
real-time qRT-PCR; PCRs were performed ﬁve times in
parallel (technical replicate n= 5). Total cellular RNA
was prepared using the RNeasy Mini Kit following
the manufacturer’s instructions (QIAGEN). Single
stranded cDNA was synthesized using the SuperScript
First-Strand Synthesis System according to the manu-
facturer’s protocol (Invitrogen). An equal volume mix-
ture of the products was used as templates for PCR
ampliﬁcation. Reactions were performed in a 25mL
volume with iQ SYBR Green Supermix (Bio-Rad)
and 200 nM each of forward and reverse primers
using iCycler and iQ software (Bio-Rad). Primers are
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listed in Supplementary Table S2. Concentrations of all
primers were optimized before use. PCR conditions in-
cluded an initial denaturation step of 4min at 95C fol-
lowed by 40 cycles of PCR consisting of 15 s at 95C,
30 s at 60C, and 30 s at 72C. Threshold cycle (Ct) val-
ues from the PCRs for a gene of interest (GOI) were nor-
malized against the Ct values for GAPDH from the same
cDNA sample; the results were then averaged to yield the
reported mean value and standard error of the mean.
Statistical signiﬁcance was not calculated between condi-
tions as per the guidelines described by Rieu and
Powers.29 Fold change of GOI transcript levels between
sample A and sample B equals 2DDCt, where DCt=
Ct(GOI)Ct(GAPDH) and DDCt=DCt(A)DCt(B).
ELISA
A sample of trachea and vasculature efﬂuent (biological
replicate n= 1) was collected after 24 h of culturing the
pig lung in the bioreactor system and used to analyze se-
creted surfactant protein C values using ELISA Standard
Kits from Life Sciences Advanced Technologies accord-
ing to the manufacturer’s instructions. Blankmedia were
run as a control and the resulting average value sub-
tracted from the measurements from collected culture
media samples. Technical replicate n= 4; error bars
shown are standard error across replicates.
Results
To utilize the bioreactor for lung culture, a freshly iso-
lated and heparinized organ is stripped of excess con-
nective tissue and cannulated with appropriate size
tubing and ﬁttings (Fig. 2A). The organ is then placed
in the silicone pleura, the pleura is sealed against the
cannulation port, and excess air is suctioned from
around the tissue. The pleura conforms to the shape
of the organ when ﬂuid is suctioned from the space
around the lung and maintains an airtight seal with
the cannulation port. This assembly, now sealed from
the atmosphere, is suspended within the organ cham-
ber and anchored to the interior stainless steel architec-
ture, after which the organ chamber is sealed with the
top plate and the glass jar ﬁlled entirely with ﬂuid, usu-
ally sterile saline. Figure 2B shows the mounted organ
at this point, limited within the silicone pleura and
mounted to all necessary ﬁttings.
A series of perfusion and ventilation pilot experi-
ments were performed, with pressure transducers placed
in the arterial, venous, and tracheal ﬂow lines. All pres-
sure transducers were external to the bioreactor cham-
ber. Selected results of these experiments can be seen
FIG. 3. Histology of native lung after 24 h
culture. H&E sections showed low levels of tissue
damage and maintenance of overall tissue
morphology (A, B). CD31 expression decreased in
some alveolar regions (C, D), perhaps due to use
of medium that is not optimized for endothelial
culture. Epithelial secretion was fairly well
maintained in both alveolar (pro-SPC staining,
E, F) and bronchial (CCSP staining, G, H) regions.
AQP-5 appeared increased in the cultured lung
compared to native (I, J). Cell proliferation
decreased during culture, demonstrated by PCNA
staining as can be seen in (K, L). H&E, hematoxylin
and eosin.
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in Figure 2C–F, which demonstrate the varying capabil-
ities of both perfusion and breathing in this system.
First, a porcine left lung was perfused at 20 bpm,
24.5mL/stroke, with the airways ﬁlled with air and ve-
nous drainage into the pleural space. Figure 2C shows
the resulting (PA)-line pressure measurements. These
curves display physiologic-like patterns, including a vis-
ible dicrotic notch from the closure of the poppet valves
in the vascular pump. In separate experiments, left and
right porcine lungs were mounted in the bioreactor
and perfused at 66 bpm, 30mL/stroke, with cannulated
pulmonary veins and ﬂuid-ﬁlled airways. Figure 2D
shows pressure contours for the resulting venous out-
ﬂow, which display expected smooth proﬁles and rela-
tively small pressure changes. Filling the airways with
ﬂuid allowed the measurement of tracheal pressures,
and Figure 2E shows the pressure proﬁle for the trachea
line of a pair of lungs when negative pressure ventilated
with ﬂuid at 7.1 cycles/min, 150mL/cycle. The lower
portion of the waveform corresponds to inhalation
and upper portion corresponds to exhalation. Continu-
ous simultaneous perfusion and ventilation were also
demonstrated, with Figure 2F showing a result from
the PA-line cannulated to a left lobe when both perfu-
sion and ventilation are underway, with the narrow
peaks corresponding to the vascular perfusion rate and
the larger sinusoidal amplitude due to ventilation-
induced pressure shifts. Additional relevant pressure
contours can be found in Supplementary Figure S2.
A 24-h culture with continuous perfusion and ﬂuid
ventilation was then performed to assess the reactor’s
ability to support the metabolic demands of fully cellular
tissue. A porcine left lung was mounted as described for
Figure 1 and was perfused with high-glucose (4,500mg/
L) DMEM at 24.5mL/stroke, 5 bpm (*120mL/min)
and ventilated with the same medium mixture at
FIG. 4. Gene expression by RT-PCR of native lung and after 24 h culture. Corresponding to the histological
ﬁndings, epithelial secretion was well maintained during culture, as can be seen in measurements of CCSP, SPC,
and SPB expression in (A–C). Endothelial gene expression was also maintained, with VE-cadherin expression
and CD31 expression remaining close to pre-bioreactor values (D, E). A sixfold increase in p63 expressions was
seen (F), suggesting active regulation of proliferation and differentiation of airway precursor cells, which are
expected in the setting of lung ‘‘injury.’’ An increase in FoxJ1, a marker of ciliation, was observed as well (G). SPC
concentration was slightly higher in tracheal ﬂuid than in vascular ﬂuid, suggesting a partial mechanical barrier
between capillary and alveolar lumens (H). Error bars are standard error of the mean across technical replicates
(n = 5); however, statistical signiﬁcance between conditions was not calculated as per the recommendation of
Rieu et al., as this data come from multiple samples from a single lung (biological replicate n = 1).
Raredon, et al.; BioResearch Open Access 2016, 5.1
http://online.liebertpub.com/doi/10.1089/biores.2016.0006
80
300mL/stroke, 2 breaths per min. Sections of the tissue
were taken after 24 h of culture at 37C and were com-
pared to sections from the right lung of the same animal
ﬁxed immediately before left lung culture. H&E section-
ing (Fig. 3A, B) showed maintenance of tissue morphol-
ogy, intact alveoli, few dead cells, and normal tissue
organization. CD31 expression was observed more
clearly in native as opposed to 24-h cultured lungs
(Fig. 3C, D), implying some loss of capillary integrity.
This could be due to the used parameters not providing
adequate nutrient medium to the overall lung tissue or to
insufﬁcient shear stresses in the pulmonary microvascu-
lature. Epithelial survival and secretory markers were
well maintained, with pro-SPC expression remaining
distinct (Fig. 3E–F) and CCSP also still clearly visible
in the larger airways (Fig. 3G–H), despite the use of
ﬂuid ventilation for 24 h. The chosen culture conditions
did seem to have a potent effect on aquaporin-5 (AQP-5)
expression, with the tissue displaying a widespread in-
crease in alveolar expression of AQP-5 after 24 h of liq-
uid ventilation (Fig. 3I–J). Although the precise cause for
the apparent increase in AQP-5 by immunostaining is
unclear, the role of the water channel AQP-5 in ﬂuid
clearance from alveoli may underlie its increase in the
setting of liquid ventilation. Cell proliferation decreased
following bioreactor culture, as observed through PCNA
staining, and may be due to overall low nutrient delivery
at the ﬂow rates and volumes used for this experiment
(Fig. 3K–L).
Multiple tissue samples were taken from the same
experiment and assessed for gene expression using
real-time qRT-PCR. Markers of epithelial secretion
were well maintained during bioreactor culture, with
graphs of normalized CCSP, SPC, and SPB expression
FIG. 5. Bioreactor-actuated decellularization. A complete set of porcine lungs was loaded into the reactor
immediately following excision (A). The organ was decellularized over a period of 6 h and then rinsed
overnight, yielding a robust acellular scaffold (B). Histology from the decellularized organ (D) compared to
native tissue (C) showed successful removal of cells from both the vascular and epithelial spaces and
widespread intact matrix architecture.
Raredon, et al.; BioResearch Open Access 2016, 5.1
http://online.liebertpub.com/doi/10.1089/biores.2016.0006
81
shown in Figure 4A–C. Vascular markers showed sim-
ilar low-fold changes (Fig. 4D, 4E). A sixfold increase in
expression of p63 was seen (Fig. 4F), suggesting that the
chosen culture conditions were affecting cell prolifera-
tion or development. FoxJ1 also showed an increase in
expression (Fig. 4G), suggesting potential promotion of
ciliogenesis. To assess barrier function, a ﬁnal experi-
ment was performed in which media samples were
taken from the tracheal and vascular spaces and surfac-
tant levels compared. ELISA data for this assay can be
seen in Figure 4H, showing a higher concentration of
secreted components in the airways than in the vascu-
lature, a ﬁnding suggesting that there is still an intact
mechanical barrier between the physiologic spaces.
However, the presence of signal for surfactant protein
in the vascular perfusion loops means that there was
some breakdown of barrier function compared to na-
tive tissue during the 24 h culture period.
To assess whether the bioreactor apparatus could be
used to decellularize an entire organ, a set of intact porcine
lungs were cannulated through the pulmonary artery,
veins, and trachea. The lungs were placed within the reac-
tor without a silicone pleura,perfused, and ventilated with
previously described decellularizing solutions (Petersen
et al.1). The construct was then rinsed extensively with
PBS through both the airways and vasculature and tissue
sections taken for histology. The resulting lungs showed
consistent decellularization of the entire organ, mainte-
nance of extracellular matrix architecture, and successful
removal of all cell types (Fig. 5).
Discussion
We have developed a system that ﬁlls a necessary gap in
current technology for whole-organ regeneration.
There is currently a critical need in regenerative medi-
cine for advanced functional bioreactors that are scaled
for clinical application. We have addressed this need by
designing an apparatus specially tailored to human-
scale whole-lung decellularization and long-term cul-
ture. Particular care has been taken to allow the
ex vivo creation and maintenance of a macroscopic bio-
mimetic mechanical environment, which is crucial for
proper cellular development in the lung.
The artiﬁcial diaphragm in the bioreactor is a signiﬁ-
cant improvement over other ex vivo ventilation assem-
blies, as it allows ﬁne control of negative-pressure
ventilation over a wide range of physiologic rates. The
perfusion system also sets itself apart from commercially
available whole-organ systems as it can achieve vascular
ﬂow rates found in the body while displaying pressure
contours similar to those generated by the heart. Finally,
the incorporation of a ﬂexible pleura around the organ
obviates many of the challenges associated with
decellularization-based pulmonary regeneration, allow-
ing ﬂuid suspension while helping to maintain sterility
and reducing media requirements, which might help
this technique to come within ﬁnancial reach of a
broad range of laboratories.
The bioreactor has proven to be a useful tool for
decellularization, capable of removing the majority of
cellular material with minimal optimization of me-
chanical parameters.
Histology and RT-PCR suggest that the reactor is
able to keep fully cellular tissue alive and functional, al-
though the chosen experimental parameters are clearly
not optimized yet to produce an environment identical
to that found in vivo. It should be noted that culture
medium composition plays a signiﬁcant role in mediat-
ing cell morphology and function, and the medium
used here as not optimized for epithelial–endothelial
coculture. Further studies must be done to determine
both optimal media and optimal patterns of mechani-
cal actuation for long-term culture.
We have demonstrated the intended function of the
apparatus for a number of use cases, including whole-
organ culture and decellularization, as well as breathing
and perfusion.We feel conﬁdent that the described appa-
ratus will be immediately useful for disciplines involving
both whole-organ regeneration and ex vivo pulmonary
studies. Such specialized technical tools are going to be-
come increasingly important in the coming decades as
whole-organ regenerative technology edges toward the
clinic. This prototype presents multiple improvements
on existing technologies and represents the next step
in what we hope to be many generations of iteratively
better technologies furthering organ regeneration.
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Abbreviations Used
bpm ¼ beats per minute
brpm ¼ breaths per minute
DMEM ¼ Dulbecco’s modiﬁed Eagle’s medium
EVLP ¼ ex vivo lung perfusion
FBS ¼ fetal bovine serum
GOI ¼ gene of interest
H&E ¼ hematoxylin and eosin
NPT ¼ national pipe thread
PBS ¼ phosphate-buffered saline
qRT-PCR ¼ quantitative reverse transcription polymerase
chain reaction
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